Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Classified as a cosmetic product, it is entirely plant-based, setting it apart from medical-grade alternatives
Competitive Landscape The Middle East and African Glucagon-like Peptide-1 (GLP-1) Agonists Market is consolidated, with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, and AstraZeneca, holding their presence in all regions
Two shots per day (AM fasted + PM bedtime) is used when protocols target sustained pulse coverage
The availability of oral formulations addresses patient preferences for non-injectable medications while the entry of additional manufacturers beyond the current duopoly is expected to improve supply availability and create pricing competition that will facilitate broader access
Please confirm before placing an order
US$ 28.09
US$ 20.39
US$ 29.29
US$ 25.32
